Overview
This page compares Injective and UUSD with live PEPS metrics. Rankings (#99 vs #256) and liquidity profiles differ, so traders often use them for distinct roles rather than as perfect substitutes.
Quick winners
Full comparison
| Metric | INJ | UUSD |
|---|---|---|
| Price | $5.07 | $1,880.40 |
| Market Cap | $490.41M | $99.77M |
| FDV | — | — |
| Volume 24h | $2.62M | $473,925.00 |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 256.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.78% | +3.50% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | UUSD |
|---|---|---|
| 1H | — | — |
| 24H | +3.42% | +0.00% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | UUSD |
|---|---|---|
| RSI | 53.92 | 54.31 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 66.45 |
| ADX | 12.69 | 20.44 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.47 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 59.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Indicator stacks for INJ/UUSD currently lean on separate regimes: neutral versus bearish. Treat MACD and RSI as context, not as standalone entry triggers.
Fundamentals
| Metric | INJ | UUSD |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
UUSD
Pros and cons
Pros of Injective
- Market-cap scale on Injective may dampen some idiosyncratic shocks versus smaller peers.
- INJ often anchors narratives that attract sustained media and analyst coverage.
- Injective has an established coin page footprint on PEPS for continuous monitoring.
Cons of Injective
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Regulatory or macro headlines can hit Injective harder simply because it is more visible.
- Indicator stacks on Injective may stay stretched longer than expected in strong trends.
Pros of UUSD
- If technical momentum aligns, UUSD may outperform on medium-term windows.
- PEPS tracking for UUSD still includes AI score and level context for monitoring.
- Diversifying versus Injective with UUSD can change portfolio factor exposure.
Cons of UUSD
- Higher volatility on UUSD cuts both ways and demands stricter risk limits.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Trend failures on UUSD often travel faster than on more established assets.
- Relative underperformance versus Injective can persist through entire market regimes.
Which looks stronger right now?
Data currently points to a probabilistic edge for Injective on size and Injective on activity. Neither reading guarantees future returns.
AI summary
This AI-assisted summary starts from live PEPS fields. Injective holds market-cap $490.41M and rank #99; UUSD shows $99.77M and #256. Where liquidity and flow matter, watch Injective. Where durability matters, watch Injective. AI composite scores (48.80/56.80) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, Injective or UUSD?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or UUSD?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and UUSD.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.